XtalPi Holdings Ltd
2228
Rank in Stocks
#4646
XtalPi Holdings Limited functions as an investment holding company, delivering... XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
Share Price
$0.74616501
Market Cap
$3.21B
Change (1 day)
-4.10%
Change (1 year)
-50.36%
Country
CN
Trade XtalPi Holdings Ltd (2228)
Category
Healthcare
P/S ratio for XtalPi Holdings Ltd (2228)
P/S ratio as of October 2026 TTM: 32.02
According to XtalPi Holdings Ltd latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 32.02. At the end of 2024 the company had a P/S ratio of 40.47.
P/S ratio history for XtalPi Holdings Ltd from 2024 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 32.02 | -22.10% |
| 2025 | 41.11 | 1.57% |
| 2024 | 40.47 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 10.02 | -68.70% |
US
|
|
| 40.55 | 26.63% |
US
|
|
| 4.19 | -86.91% |
AU
|
|
| 10.44 | -67.39% |
NL
|
|
| - | - |
CH
|
